X
NVCR icon

Xponance’s NovoCure NVCR Stock Holding History

Xponance’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+10,331
New +$156K ﹤0.01% 1655
2025
Q1 		– Sell
-7,762
Closed -$231K – 1470
2024
Q4 		$231K Buy
+7,762
New +$164K ﹤0.01% 1238
2024
Q2 		– Sell
-13,623
Closed -$213K – 1353
2024
Q1 		$213K Sell
13,623
-352
-3% -$5.18K ﹤0.01% 1171
2023
Q4 		$209K Sell
13,975
-400
-3% -$5.35K ﹤0.01% 1147
2023
Q3 		$232K Buy
14,375
+8
+0.1% +$231 ﹤0.01% 1091
2023
Q2 		$596K Buy
14,367
+260
+2% +$16.1K 0.01% 834
2023
Q1 		$848K Buy
14,107
+105
+0.7% +$8.39K 0.01% 709
2022
Q4 		$1.03M Buy
14,002
+1,778
+15% +$134K 0.02% 630
2022
Q3 		$929K Buy
12,224
+202
+2% +$15.8K 0.02% 604
2022
Q2 		$836K Buy
12,022
+383
+3% +$28.9K 0.02% 632
2022
Q1 		$964K Buy
11,639
+133
+1% +$9.8K 0.02% 606
2021
Q4 		$864K Sell
11,506
-184
-2% -$18.5K 0.01% 667
2021
Q3 		$1.36M Sell
11,690
-274
-2% -$41.4K 0.03% 454
2021
Q2 		$2.65M Buy
11,964
+1,570
+15% +$305K 0.05% 301
2021
Q1 		$1.37M Sell
10,394
-94
-0.9% -$14.9K 0.03% 390
2020
Q4 		$1.81M Buy
10,488
+86
+0.8% +$11.8K 0.04% 329
2020
Q3 		$1.16M Sell
10,402
-37
-0.4% -$2.96K 0.03% 387
2020
Q2 		$619K Buy
+10,439
New +$687K 0.02% 509

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Xponance's NVCR Position: Q2 2026 in Review

Xponance opened a new position in NovoCure (NVCR) in Q2 2026: 10,331 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #1655 among its holdings. This is a return to the name: Xponance previously reported a position in NVCR as recently as Q4 2024.

Xponance first reported a position in NVCR in Q2 2020 and has held it in 18 quarters since. The position peaked at $2.65M in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Xponance held 10,331 shares of NovoCure worth $157K as of Q2 2026.
  • NovoCure was a new Xponance position in Q2 2026.
  • NovoCure made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1655 holding.
  • Xponance first reported a position in NovoCure in Q2 2020 and has held it in 18 quarters since.
  • Xponance's NovoCure position peaked at $2.65M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.